IL86302A0 - Pharmaceutical combination for the prophylaxis and therapy of malaria - Google Patents

Pharmaceutical combination for the prophylaxis and therapy of malaria

Info

Publication number
IL86302A0
IL86302A0 IL86302A IL8630288A IL86302A0 IL 86302 A0 IL86302 A0 IL 86302A0 IL 86302 A IL86302 A IL 86302A IL 8630288 A IL8630288 A IL 8630288A IL 86302 A0 IL86302 A0 IL 86302A0
Authority
IL
Israel
Prior art keywords
malaria
prophylaxis
therapy
pharmaceutical combination
pharmaceutical
Prior art date
Application number
IL86302A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL86302A0 publication Critical patent/IL86302A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL86302A 1987-05-08 1988-05-06 Pharmaceutical combination for the prophylaxis and therapy of malaria IL86302A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873715378 DE3715378A1 (de) 1987-05-08 1987-05-08 Arzneimittelkombination zur prophylaxe und therapie von malaria

Publications (1)

Publication Number Publication Date
IL86302A0 true IL86302A0 (en) 1988-11-15

Family

ID=6327117

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86302A IL86302A0 (en) 1987-05-08 1988-05-06 Pharmaceutical combination for the prophylaxis and therapy of malaria

Country Status (11)

Country Link
EP (1) EP0290959A3 (xx)
JP (1) JPS6452714A (xx)
KR (1) KR880013558A (xx)
AU (1) AU614515B2 (xx)
DE (1) DE3715378A1 (xx)
DK (1) DK249688A (xx)
HU (1) HU200688B (xx)
IL (1) IL86302A0 (xx)
IN (1) IN166154B (xx)
PT (1) PT87427B (xx)
ZA (1) ZA883209B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
DE68906345T2 (de) * 1988-10-07 1993-10-28 Hoechst Ag Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
EP0535719A3 (en) * 1988-12-06 1993-04-14 Dermatologic Research Corporation Treatment of hemorrhoids with artemisinin and derivates
EP0464233A1 (en) * 1990-07-02 1992-01-08 Hoechst Aktiengesellschaft Pharmaceutical combinations against malaria
NZ246606A (en) * 1992-02-07 1995-09-26 Ciba Geigy Ag Antimalarial compostions containing a synergistic combination of benflumetol and quinine or a derivative thereof
GB9622427D0 (en) * 1996-10-28 1997-01-08 Pharma Mar Sa Antimalarial drugs
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
IN191696B (xx) * 1999-02-12 2003-12-20 Council Scient Ind Res
BR0017199A (pt) * 2000-03-28 2003-04-08 Council Scient Ind Res Composição antimicrobiana e um processo para produção da mesma
AU2001295979A1 (en) * 2000-10-20 2002-04-29 Ajinomoto Co., Inc. Medicinal compositions, dose and method for treating malaria
CN1255106C (zh) 2003-09-26 2006-05-10 李国桥 复方青蒿素
WO2006070393A1 (en) * 2004-12-28 2006-07-06 Council Of Scientific And Industrial Research SYNERGISTIC COMBINATION KIT OF α,ß-ARTEETHER, SULFADOXIN AND PYMETHAMINE FOR TREATMENT OF SEVERE/MULTI-DRUG RESISTANT CEREBRAL MALARIA
FR2884715B1 (fr) * 2005-04-20 2007-06-15 Sanofi Aventis Sa Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme
WO2007043061A1 (en) * 2005-10-11 2007-04-19 Ipca Laboratories Ltd. Anti-malarial combination and methods of formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
DE68906345T2 (de) * 1988-10-07 1993-10-28 Hoechst Ag Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.

Also Published As

Publication number Publication date
DE3715378A1 (de) 1988-11-24
HU200688B (en) 1990-08-28
ZA883209B (en) 1988-11-08
DK249688D0 (da) 1988-05-06
PT87427A (pt) 1989-05-31
PT87427B (pt) 1992-09-30
EP0290959A2 (de) 1988-11-17
IN166154B (xx) 1990-03-24
EP0290959A3 (de) 1990-03-07
KR880013558A (ko) 1988-12-21
AU1567588A (en) 1988-11-10
DK249688A (da) 1988-11-09
AU614515B2 (en) 1991-09-05
HUT47846A (en) 1989-04-28
JPS6452714A (en) 1989-02-28

Similar Documents

Publication Publication Date Title
GB2204237B (en) Agents for the prophylaxis and therapy of retroviral infections
EP0491861A4 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
CS403391A3 (en) Pharmaceutical
GB8812914D0 (en) Treatment of materials
AU2914889A (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
NZ226002A (en) Peptidylheterocyclic compounds and pharmaceutical compositions
IL86302A0 (en) Pharmaceutical combination for the prophylaxis and therapy of malaria
EP0304802A3 (en) Pharmaceutical composition and the use thereof
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
PH23235A (en) Combination preparations for the treatment of malaria
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
EP0400075A4 (en) Enhancement of the therapeutic properties of glycoprotein
GB8712240D0 (en) Pharmaceutical formulation
GB2220652B (en) Treatment of pastures
EP0305902A3 (en) Medicament
IL88566A (en) Composition for the reduction of phlebectasiae and its preparation
IL86116A0 (en) Pharmaceutical compositions for the treatment of malaria
ZA882667B (en) Agents for the prophylaxis and therapy of retroviral infections
GR871526B (en) Medicine for fighting the psoriasis and the eczema
IE872788L (en) Pharmaceutical combination
GB8727005D0 (en) Administration of pharmaceutical products
GB8719374D0 (en) Pharmaceutical devices
NZ221377A (en) Diselenobis benzamides and pharmaceutical compositions
GB8705553D0 (en) Medicament
IE881376L (en) Anti-malarial pharmaceutical combination